Puyallup, WA, United States of America

Donald Robert VanDevanter


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donald Robert VanDevanter: Innovator in Antimicrobial Solutions

Introduction

Donald Robert VanDevanter is a distinguished inventor based in Puyallup, Washington, who has made significant contributions to medical science with his innovative approach to treating pulmonary bacterial infections. His pioneering work focuses on combatting antibiotic-resistant bacteria, particularly in the context of severe infections associated with Pseudomonas aeruginosa.

Latest Patents

VanDevanter holds a notable patent for "Pure biologically active colistin, its components and a colistin." This patent outlines an anti-Pseudomonas aeruginosa agent that is substantially pure and biologically active. It encompasses a formulation and method for preparing colistin, which can be delivered as either an aerosol or dry powder formulation. Additionally, the patent details a method for both the treatment and prophylaxis of infections caused by Pseudomonas aeruginosa and Stenotrophomonas maltophilia, among other susceptible pulmonary bacterial pathogens.

Career Highlights

VanDevanter is actively associated with Pathogenesis Corporation, where he continues to innovate in the field of antimicrobial research. His single patent underlines his commitment to addressing critical health challenges posed by drug-resistant bacteria.

Collaborations

Throughout his career, VanDevanter has collaborated with Alan B. Montgomery, a fellow innovator in the field. Their partnership reflects a dedication to advancing medical research and developing effective treatments for serious bacterial infections, enhancing the quality of care available to patients.

Conclusion

Donald Robert VanDevanter’s innovative contributions to the field of antimicrobial solutions illustrate the importance of ongoing research and development in medicine. His work, particularly in developing a method to deliver biologically active colistin, signifies a crucial step forward in combating antibiotic resistance and improving treatment options for pulmonary infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…